Thompson Rubinstein Investment Management’s Edwards Lifesciences EW Stock Holding History

Thompson Rubinstein Investment Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$529K	Hold	8,295	–	–	0.17%	65
2018 Q4	$424K	Hold	8,295	–	–	0.16%	66
2018 Q3	$481K	Sell	8,295 -423	-5%	-$20.7K	0.15%	68
2018 Q2	$423K	Hold	8,718	–	–	0.14%	69
2018 Q1	$405K	Hold	8,718	–	–	0.14%	69
2017 Q4	$328K	Hold	8,718	–	–	0.11%	74
2017 Q3	$318K	Sell	8,718 -912	-9%	-$34.8K	0.11%	75
2017 Q2	$380K	Sell	9,630 -2,400	-20%	-$87.6K	0.14%	73
2017 Q1	$377K	Hold	12,030	–	–	0.14%	71
2016 Q4	$376K	Hold	12,030	–	–	0.14%	69
2016 Q3	$483K	Hold	12,030	–	–	0.18%	66
2016 Q2	$400K	Hold	12,030	–	–	0.16%	70
2016 Q1	$354K	Hold	12,030	–	–	0.14%	70
2015 Q4	$317K	Hold	12,030	–	–	0.15%	69
2015 Q3	$285K	Hold	12,030	–	–	0.13%	68
2015 Q2	$286K	Hold	12,030	–	–	0.11%	71
2015 Q1	$286K	Sell	12,030 -41,238	-77%	-$925K	0.11%	69
2014 Q4	$1.13M	Sell	53,268 -271,482	-84%	-$5.45M	0.43%	54
2014 Q3	$5.53M	Sell	324,750 -39,810	-11%	-$628K	2.18%	18
2014 Q2	$5.22M	Hold	364,560	–	–	1.97%	18
2014 Q1	$4.51M	Buy	364,560 +14,046	+4%	+$162K	1.8%	22
2013 Q4	$3.84M	Buy	350,514 +331,884	+1,781%	+$3.74M	1.51%	28
2013 Q3	$216K	Buy	+18,630	New	+$218K	0.09%	67

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Thompson Rubinstein Investment Management's EW Position: Q1 2019 in Review

Thompson Rubinstein Investment Management held its Edwards Lifesciences (EW) position steady in Q1 2019 at 8,295 shares worth $529K. The position accounts for 0.17% of the portfolio, ranked #65.

Thompson Rubinstein Investment Management first reported a position in EW in Q3 2013 and has held it in 23 quarters since. The position peaked at $5.53M in Q3 2014. 922 funds tracked by Wall St. Rank hold EW as of Q1 2019.

Thompson Rubinstein Investment Management held 8,295 shares of Edwards Lifesciences worth $529K as of Q1 2019.
Thompson Rubinstein Investment Management left its Edwards Lifesciences share count unchanged in Q1 2019.
Edwards Lifesciences made up 0.17% of Thompson Rubinstein Investment Management's portfolio in Q1 2019, its #65 holding.
Thompson Rubinstein Investment Management first reported a position in Edwards Lifesciences in Q3 2013 and has held it in 23 quarters since.
Thompson Rubinstein Investment Management's Edwards Lifesciences position peaked at $5.53M in Q3 2014.
922 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2019.

Based on Thompson Rubinstein Investment Management's 13F filing for Q1 2019, filed 4 Apr 2019.